CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China
· Delayed Price · Currency is CNY 30.14
-1.23 (-3.92%)
Apr 28, 2026, 3:04 PM CST
SHE:300765 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 2,307 | 2,114 | 1,928 | 2,485 | 2,571 | 1,790 | Upgrade
|
| Other Revenue | 43.33 | 43.33 | 52.64 | 53.66 | 55.25 | 60.14 | Upgrade
|
| Revenue | 2,350 | 2,158 | 1,981 | 2,539 | 2,626 | 1,850 | Upgrade
|
| Revenue Growth (YoY) | 21.87% | 8.93% | -21.98% | -3.34% | 42.00% | 40.40% | Upgrade
|
| Cost of Revenue | 1,445 | 1,338 | 1,155 | 1,383 | 1,493 | 1,043 | Upgrade
|
| Gross Profit | 905.03 | 819.96 | 825.52 | 1,155 | 1,133 | 807.09 | Upgrade
|
| Selling, General & Admin | 388.28 | 372.76 | 233.37 | 302.21 | 312.29 | 323.91 | Upgrade
|
| Research & Development | 1,069 | 1,036 | 842.2 | 671.4 | 46.3 | 26.5 | Upgrade
|
| Other Operating Expenses | 34.46 | 28.93 | 29.57 | 32.73 | 19.92 | 15.75 | Upgrade
|
| Operating Expenses | 1,502 | 1,446 | 1,102 | 1,001 | 386.31 | 372.19 | Upgrade
|
| Operating Income | -597.14 | -625.75 | -276.66 | 153.8 | 747.14 | 434.9 | Upgrade
|
| Interest Expense | -31.92 | -21.82 | -6.37 | -17.63 | -0.22 | -2.83 | Upgrade
|
| Interest & Investment Income | 11.82 | 11.06 | 42.21 | 85.92 | 49.57 | 45.37 | Upgrade
|
| Currency Exchange Gain (Loss) | 18.56 | 18.56 | 7.44 | 25.17 | 55.21 | -7.07 | Upgrade
|
| Other Non Operating Income (Expenses) | -26.15 | -0.6 | -1.07 | 1.4 | -0.98 | -1.08 | Upgrade
|
| EBT Excluding Unusual Items | -624.84 | -618.55 | -234.45 | 248.65 | 850.72 | 469.29 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -3.47 | Upgrade
|
| Gain (Loss) on Sale of Investments | -10.18 | -7.03 | -0.89 | - | - | 3.59 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.08 | 2.78 | 0.71 | 0.33 | 1.61 | 0.38 | Upgrade
|
| Asset Writedown | -3.66 | -3.66 | -3.1 | -2.15 | -6.17 | -10.1 | Upgrade
|
| Other Unusual Items | 94.57 | 74.91 | 16.43 | 15.15 | 5.22 | 18.3 | Upgrade
|
| Pretax Income | -543.02 | -551.54 | -221.3 | 262.14 | 851.37 | 477.99 | Upgrade
|
| Income Tax Expense | 53.82 | 57.8 | 81.91 | 136.47 | 124.76 | 85.29 | Upgrade
|
| Earnings From Continuing Operations | -596.84 | -609.34 | -303.21 | 125.67 | 726.61 | 392.7 | Upgrade
|
| Minority Interest in Earnings | 288.76 | 368.21 | 356.94 | 308.77 | -0.33 | 0.53 | Upgrade
|
| Net Income | -308.08 | -241.13 | 53.73 | 434.44 | 726.28 | 393.23 | Upgrade
|
| Net Income to Common | -308.08 | -241.13 | 53.73 | 434.44 | 726.28 | 393.23 | Upgrade
|
| Net Income Growth | - | - | -87.63% | -40.18% | 84.70% | 31.15% | Upgrade
|
| Shares Outstanding (Basic) | 1,391 | 1,393 | 1,399 | 1,397 | 1,337 | 1,337 | Upgrade
|
| Shares Outstanding (Diluted) | 1,391 | 1,393 | 1,399 | 1,397 | 1,337 | 1,337 | Upgrade
|
| Shares Change (YoY) | -0.54% | -0.44% | 0.16% | 4.50% | -0.02% | 13.53% | Upgrade
|
| EPS (Basic) | -0.22 | -0.17 | 0.04 | 0.31 | 0.54 | 0.29 | Upgrade
|
| EPS (Diluted) | -0.22 | -0.17 | 0.04 | 0.31 | 0.54 | 0.29 | Upgrade
|
| EPS Growth | - | - | -87.65% | -42.76% | 84.73% | 15.52% | Upgrade
|
| Free Cash Flow | -868.11 | -764.08 | -1,713 | 139.72 | 526.67 | 96.67 | Upgrade
|
| Free Cash Flow Per Share | -0.62 | -0.55 | -1.22 | 0.10 | 0.39 | 0.07 | Upgrade
|
| Dividend Per Share | - | - | 0.020 | 0.267 | 0.069 | 0.069 | Upgrade
|
| Dividend Growth | - | - | -92.50% | 284.29% | - | 94.94% | Upgrade
|
| Gross Margin | 38.51% | 38.00% | 41.68% | 45.51% | 43.15% | 43.63% | Upgrade
|
| Operating Margin | -25.41% | -29.00% | -13.97% | 6.06% | 28.45% | 23.51% | Upgrade
|
| Profit Margin | -13.11% | -11.18% | 2.71% | 17.11% | 27.65% | 21.26% | Upgrade
|
| Free Cash Flow Margin | -36.94% | -35.41% | -86.47% | 5.50% | 20.05% | 5.23% | Upgrade
|
| EBITDA | -373.51 | -403.57 | -60.31 | 308.55 | 819.26 | 504.05 | Upgrade
|
| EBITDA Margin | -15.89% | -18.70% | -3.04% | 12.15% | 31.19% | 27.25% | Upgrade
|
| D&A For EBITDA | 223.63 | 222.17 | 216.35 | 154.76 | 72.12 | 69.15 | Upgrade
|
| EBIT | -597.14 | -625.75 | -276.66 | 153.8 | 747.14 | 434.9 | Upgrade
|
| EBIT Margin | -25.41% | -29.00% | -13.97% | 6.06% | 28.45% | 23.51% | Upgrade
|
| Effective Tax Rate | - | - | - | 52.06% | 14.65% | 17.84% | Upgrade
|
| Revenue as Reported | 2,350 | 2,158 | 1,981 | 2,539 | 2,626 | 1,850 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.